SI2408807T1 - Postopek za terapevtsko uporabo - Google Patents
Postopek za terapevtsko uporaboInfo
- Publication number
- SI2408807T1 SI2408807T1 SI201032083T SI201032083T SI2408807T1 SI 2408807 T1 SI2408807 T1 SI 2408807T1 SI 201032083 T SI201032083 T SI 201032083T SI 201032083 T SI201032083 T SI 201032083T SI 2408807 T1 SI2408807 T1 SI 2408807T1
- Authority
- SI
- Slovenia
- Prior art keywords
- therapeutic use
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16116509P | 2009-03-18 | 2009-03-18 | |
US25602809P | 2009-10-29 | 2009-10-29 | |
EP10710017.4A EP2408807B1 (en) | 2009-03-18 | 2010-03-18 | Method for therapeutic use |
PCT/EP2010/053519 WO2010106127A2 (en) | 2009-03-18 | 2010-03-18 | Method for therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2408807T1 true SI2408807T1 (sl) | 2021-11-30 |
Family
ID=42376556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201032083T SI2408807T1 (sl) | 2009-03-18 | 2010-03-18 | Postopek za terapevtsko uporabo |
Country Status (17)
Country | Link |
---|---|
US (1) | US20100285108A1 (sl) |
EP (2) | EP3978517A1 (sl) |
JP (2) | JP2012520852A (sl) |
KR (1) | KR20120004994A (sl) |
CN (1) | CN102428101B (sl) |
AU (1) | AU2010224824B2 (sl) |
CA (1) | CA2755683A1 (sl) |
DK (1) | DK2408807T3 (sl) |
ES (1) | ES2885398T3 (sl) |
HU (1) | HUE055739T2 (sl) |
IL (1) | IL214919A (sl) |
MX (1) | MX2011009654A (sl) |
PT (1) | PT2408807T (sl) |
RU (1) | RU2579659C2 (sl) |
SG (1) | SG174871A1 (sl) |
SI (1) | SI2408807T1 (sl) |
WO (1) | WO2010106127A2 (sl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA107571C2 (xx) | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
EP2440234A4 (en) | 2009-06-10 | 2013-11-06 | Univ New York | IMMUNOLOGICAL TARGETING OF PATHOLOGICAL TAU PROTEINS |
MX338421B (es) | 2010-10-07 | 2016-04-15 | Ac Immune Sa | Anticuerpos fosfoespecificos que reconocen la proteina tau. |
AU2013205313B2 (en) * | 2010-10-07 | 2016-05-19 | Ac Immune S.A. | Phosphospecific antibodies recognising tau |
KR20160005380A (ko) * | 2011-09-23 | 2016-01-15 | 에이씨 이뮨 에스.에이. | 백신 요법 |
RU2639537C2 (ru) * | 2011-10-07 | 2017-12-21 | Ац Иммуне С.А. | Фосфоспецифичные антитела, распознающие тау |
EP2834270B1 (en) * | 2012-04-05 | 2019-10-30 | AC Immune S.A. | Humanized tau antibody |
JP6445427B2 (ja) * | 2012-05-08 | 2018-12-26 | ウエスタン ユニバーシティ オブ ヘルス サイエンシズ | CD4+T細胞集団の抗原特異的な拡大のために標準化されたexvivoプラットフォーム |
RU2661111C2 (ru) | 2013-03-15 | 2018-07-11 | Ац Иммуне С.А. | Антитела к тау и способы применения |
US10132818B2 (en) | 2014-07-08 | 2018-11-20 | New York University | Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy |
KR102318994B1 (ko) | 2015-01-23 | 2021-10-29 | 헬릭스 바이오파마 코포레이션 | 치료학적 목적을 위한 항체-우레아제 접합체 |
EP3334453A4 (en) | 2015-08-13 | 2019-02-06 | New York University | SPECIFIC ANTIBODY MOLECULES OF THE ASP421 EPITOPE TRUNCATED FROM THE TAU PROTEIN AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF TAUOPATHY |
MA50465A (fr) * | 2017-10-25 | 2020-09-02 | Ac Immune Sa | Compositions de peptides tau phosphorylés et leurs utilisations |
CA3129252A1 (en) | 2019-02-08 | 2020-08-13 | Ac Immune S.A. | Method of safe administration of phosphorylated tau peptide vaccine |
BR112021021213A2 (pt) | 2019-04-24 | 2021-12-21 | Ac Immune Sa | Administração heteróloga de vacinas de tau |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7408027B1 (en) * | 1991-12-06 | 2008-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften | Tools for the diagnosis and treatment of Alzheimer's disease |
ES2118373T3 (es) * | 1992-12-14 | 1998-09-16 | Innogenetics Nv | Anticuerpos monoclonales dirigidos contra la proteina tau asociada a microtubulos, hibridomas que segregan estos anticuerpos, reconocimiento de antigenos por estos anticuerpos monoclonales y sus aplicaciones. |
US7427392B1 (en) * | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
US20020086009A1 (en) * | 1996-03-13 | 2002-07-04 | Koichi Ishiguro | Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
WO1998022120A1 (en) * | 1996-11-19 | 1998-05-28 | The Wistar Institute Of Anatomy & Biology | Diagnostic and therapeutic reagents for alzheimer's disease |
EP1301531A2 (en) * | 2000-07-11 | 2003-04-16 | Molecular Geriatrics Corporation | Reagents and methods for identification of binding agents |
BR0317747A (pt) | 2002-12-24 | 2005-11-22 | Neurochem Int Ltd | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave |
US8663650B2 (en) * | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
EP1494000A1 (en) * | 2003-07-02 | 2005-01-05 | Sicpa Holding S.A. | Method of marking a material with ions already comprised in said material and method of verifying the authenticity of said material |
US20050261475A1 (en) * | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
PT2465533E (pt) * | 2004-02-20 | 2015-06-24 | Ac Immune Sa | Processos e composições que têm estruturas supramoleculares |
CN101330923B (zh) * | 2005-12-12 | 2015-01-07 | Ac免疫有限公司 | 治疗性疫苗 |
US8012936B2 (en) * | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
WO2008140639A2 (en) * | 2007-02-08 | 2008-11-20 | Oligomerix, Inc. | Biomarkers and assays for alzheimer's disease |
UA107571C2 (xx) * | 2009-04-03 | 2015-01-26 | Фармацевтична композиція |
-
2010
- 2010-03-18 PT PT107100174T patent/PT2408807T/pt unknown
- 2010-03-18 KR KR1020117024550A patent/KR20120004994A/ko not_active Application Discontinuation
- 2010-03-18 DK DK10710017.4T patent/DK2408807T3/da active
- 2010-03-18 EP EP21180474.5A patent/EP3978517A1/en active Pending
- 2010-03-18 HU HUE10710017A patent/HUE055739T2/hu unknown
- 2010-03-18 US US12/661,628 patent/US20100285108A1/en not_active Abandoned
- 2010-03-18 RU RU2011141889/10A patent/RU2579659C2/ru active
- 2010-03-18 MX MX2011009654A patent/MX2011009654A/es active IP Right Grant
- 2010-03-18 JP JP2012500251A patent/JP2012520852A/ja not_active Withdrawn
- 2010-03-18 SG SG2011067097A patent/SG174871A1/en unknown
- 2010-03-18 SI SI201032083T patent/SI2408807T1/sl unknown
- 2010-03-18 WO PCT/EP2010/053519 patent/WO2010106127A2/en active Application Filing
- 2010-03-18 ES ES10710017T patent/ES2885398T3/es active Active
- 2010-03-18 AU AU2010224824A patent/AU2010224824B2/en active Active
- 2010-03-18 CN CN201080021554.XA patent/CN102428101B/zh active Active
- 2010-03-18 EP EP10710017.4A patent/EP2408807B1/en active Active
- 2010-03-18 CA CA2755683A patent/CA2755683A1/en not_active Abandoned
-
2011
- 2011-09-01 IL IL214919A patent/IL214919A/en active IP Right Grant
-
2015
- 2015-07-06 JP JP2015134900A patent/JP2015221809A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2755683A1 (en) | 2010-09-23 |
AU2010224824A1 (en) | 2011-09-22 |
RU2579659C2 (ru) | 2016-04-10 |
CN102428101B (zh) | 2016-03-02 |
PT2408807T (pt) | 2021-09-03 |
WO2010106127A3 (en) | 2011-03-31 |
ES2885398T3 (es) | 2021-12-13 |
RU2011141889A (ru) | 2013-04-27 |
IL214919A (en) | 2016-10-31 |
JP2015221809A (ja) | 2015-12-10 |
HUE055739T2 (hu) | 2021-12-28 |
AU2010224824B2 (en) | 2014-02-20 |
AU2010224824A2 (en) | 2011-09-22 |
SG174871A1 (en) | 2011-11-28 |
IL214919A0 (en) | 2011-11-30 |
DK2408807T3 (da) | 2021-08-09 |
EP2408807A2 (en) | 2012-01-25 |
CN102428101A (zh) | 2012-04-25 |
KR20120004994A (ko) | 2012-01-13 |
US20100285108A1 (en) | 2010-11-11 |
MX2011009654A (es) | 2011-10-12 |
JP2012520852A (ja) | 2012-09-10 |
WO2010106127A2 (en) | 2010-09-23 |
EP3978517A1 (en) | 2022-04-06 |
EP2408807B1 (en) | 2021-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL214919A0 (en) | Method for therapeutic use | |
GB0908957D0 (en) | Therapeutic agents | |
GB0911740D0 (en) | Improved medical apparatus | |
HK1171682A1 (en) | Therapeutic agent for rhinitis | |
GB0905377D0 (en) | Medical apparatus | |
IL217492A0 (en) | Treatment method | |
EP2324768A4 (en) | TOMOGRAPHIC PROCEDURE | |
EP2427183A4 (en) | THERAPEUTIC COMPOUNDS | |
GB0914543D0 (en) | Radioiodination method | |
EP2510949A4 (en) | THERAPEUTICS FOR FIBROMYALGIA | |
EP2496704A4 (en) | THERAPEUTIC COMPOUNDS | |
GB0901465D0 (en) | Compounds for use in therapy | |
GB0918347D0 (en) | Medical apparatus | |
GB0917447D0 (en) | Medical apparatus | |
GB0901483D0 (en) | Radioiodination method | |
EP2456309A4 (en) | THERAPEUTIC COMPOUNDS | |
GB0906026D0 (en) | Therapeutic compounds | |
GB0910493D0 (en) | Therapeutic agents | |
GB0814479D0 (en) | Therapeutic method | |
GB201019936D0 (en) | Therapeutic method | |
GB0914373D0 (en) | Treatment method | |
GB0921244D0 (en) | Therapy | |
GB0903319D0 (en) | Therapy | |
GB0903321D0 (en) | Therapy | |
GB0914820D0 (en) | WATerian therapy |